# A Phase I Study of TS-142 in Healthy Participants (Repeated Doses)

> **NCT04169906** · PHASE1 · COMPLETED · sponsor: **Taisho Pharmaceutical Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Placebo
- **DRUG:** TS-142, 10 mg
- **DRUG:** TS-142, 20 mg
- **DRUG:** TS-142, 30 mg

## Key facts

- **NCT ID:** NCT04169906
- **Lead sponsor:** Taisho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-06
- **Primary completion:** 2016-10-08
- **Final completion:** 2016-10-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04169906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04169906, "A Phase I Study of TS-142 in Healthy Participants (Repeated Doses)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04169906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*